Company intelligence / Profile preview

Advanced Wound Products

USA

Ownership: Private
Development stage: Other

Overview

Advanced Wound Products distributes amniotic membrane allografts (BioLab Membrane Wrap, Membrane Wrap – Hydro, Tri-Membrane Wrap, XCell Amnio Matrix) that are used in chronic and acute wound management. These products are screened, sterilized, and controlled for safety and efficacy. Clinical results show benefits in tissue repair, reduced healing time, and effectiveness in diverse wound types

Therapeutic areas: OtherEndocrinologyDermatologyCardiovascular
Modalities: BiologicAmniotic membrane allograftBiological dressing
Industry: Consumable Medical Devices

Partnerships

company offers distribution partnerships for wound care providers

Beyond the preview

Go deeper on Advanced Wound Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Wound Products.

Explore the full profile